Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease

János Nemcsik1, István Kiss, András Tislér

  • 1János Nemcsik, Department of Family Medicine, Semmelweis University, 1125 Budapest, Hungary.

Insights

Chronic kidney disease (CKD) accelerates arterial stiffness and calcification, linked to impaired bone metabolism. This review explores the bone-vascular axis in CKD, detailing factors influencing vascular calcification and arterial stiffness.

Area of Science:

  • Nephrology
  • Cardiology
  • Bone Metabolism

Background:

  • Patients with chronic kidney disease (CKD) exhibit significantly worse cardiovascular outcomes.
  • Arterial stiffness, a key predictor of survival in CKD, is closely associated with arterial media calcification.
  • The progression of arterial calcification and stiffness in CKD occurs concurrently with disturbed bone metabolism.

Purpose of the Study:

  • To elucidate the mechanisms driving increased arterial stiffness in CKD.
  • To present current data on the bone-vascular axis within the context of CKD.
  • To review factors contributing to vascular calcification and their impact on arterial stiffness.

Main Methods:

  • Literature review of scientific results.
  • Analysis of the bone-vascular axis in CKD.
  • Overview of factors influencing vascular calcification and arterial stiffness.

Main Results:

  • CKD is characterized by increased arterial calcification and stiffness, paralleled by impaired bone metabolism.
  • A complex interplay exists between bone metabolism and vascular health in CKD, termed "CKD mineral bone disorder".
  • Several bone-related factors, including osteoprotegerin, fetuin-A, and fibroblast growth factor 23, are implicated in vascular calcification and arterial stiffness.

Conclusions:

  • The "CKD mineral bone disorder" highlights the strong connection between bone and vascular pathologies in CKD.
  • Understanding the bone-vascular axis is crucial for managing cardiovascular risks in CKD patients.
  • Further research into specific bone-related factors may reveal therapeutic targets for reducing arterial stiffness and calcification in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773